In Pain relief Divi M Injection helps to relieve pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis, juvenile arthritis, and osteoarthritis. It is given as an injection by a doctor or nurse and should not be self-administered. The dose and duration will be decided by the doctor depending on the condition you are being treated for. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Caution is advised when consuming alcohol with Divi M Injection. Please consult your doctor.
Divi M Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Divi M Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Divi M Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Divi M Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Divi M Injection may be needed. Please consult your doctor. Limited information is available on the use of Divi M Injection in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Divi M Injection should be used with caution in patients with severe liver disease. Dose adjustment of Divi M Injection may be needed. Please consult your doctor.
If you miss a dose of Divi M Injection, consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More